C96 Category · further specificity required Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
ICD-10-CM C96 identifies “Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue” as a category requiring further specificity in the FY2027 U.S. classification, effective October 1, 2026 through September 30, 2027.
Chapter 2: Neoplasms
Code-level instructions
Excludes 11
personal history of other malignant neoplasms of lymphoid, hematopoietic and related tissues (Z85.79)
Inherited instructions
Chapters 2 · Neoplasms (C00-D49)
Note8
- Functional activity
- All neoplasms are classified in this chapter, whether they are functionally active or not. An additional code from Chapter 4 may be used, to identify functional activity associated with any neoplasm.
- Morphology [Histology]
- Chapter 2 classifies neoplasms primarily by site (topography), with broad groupings for behavior, malignant, in situ, benign, etc. The Table of Neoplasms should be used to identify the correct topography code. In a few cases, such as for malignant melanoma and certain neuroendocrine tumors, the morphology (histologic type) is included in the category and codes.
- Primary malignant neoplasms overlapping site boundaries
- A primary malignant neoplasm that overlaps two or more contiguous (next to each other) sites should be classified to the subcategory/code .8 ('overlapping lesion'), unless the combination is specifically indexed elsewhere. For multiple neoplasms of the same site that are not contiguous, such as tumors in different quadrants of the same breast, codes for each site should be assigned.
- Malignant neoplasm of ectopic tissue
- Malignant neoplasms of ectopic tissue are to be coded to the site mentioned, e.g., ectopic pancreatic malignant neoplasms are coded to pancreas, unspecified (C25.9).
C81-C96 · Malignant neoplasms of lymphoid, hematopoietic and related tissue (C81-C96)
More specific codes
C96.0Multifocal and multisystemic (disseminated) Langerhans-cell histiocytosisBillable / specificC96.2Malignant mast cell neoplasmCategory · further specificity requiredC96.4Sarcoma of dendritic cells (accessory cells)Billable / specificC96.5Multifocal and unisystemic Langerhans-cell histiocytosisBillable / specificC96.6Unifocal Langerhans-cell histiocytosisBillable / specificC96.9Malignant neoplasm of lymphoid, hematopoietic and related tissue, unspecifiedBillable / specificC96.AHistiocytic sarcomaBillable / specificC96.ZOther specified malignant neoplasms of lymphoid, hematopoietic and related tissueBillable / specificOfficial index references
References from other codes (9)
Excludes 1 · malignant neoplasm of lymphoid, hematopoietic and related tissue (C81-C96)
Excludes 1 · malignant neoplasm of lymph nodes, specified as primary (C81-C86, C88, C96.-)
Code also · malignant neoplasm (C00-C96)
Code first · malignant neoplasms (C00-C96)
Code first · malignant neoplasm (C00-C96)
Inclusion terms · Conditions in C00-C96
Code first · , if applicable, any current malignant neoplasm (C00-C75, C81-C96)
Inclusion terms · Conditions classifiable to C81-C90, C96.-
Inclusion terms · Conditions classifiable to C88-C90, C96
History
Code history
No recorded change since first observation
Effective from
- First observed
Other and unspecified malignant neoplasms of lymphoid, hematopoietic and related tissue
Category — select a more specific code
CDC/NCHS · FY2016All editions (19)
| All editions | Effective from | Code history |
|---|---|---|
| FY2016 | 2015-10-01 | First observed |
| FY2017 | 2016-10-01 | No tabular change |
| FY2018 | 2017-10-01 | No tabular change |
| FY2019 | 2018-10-01 | No tabular change |
| FY2020 | 2019-10-01 | No tabular change |
| FY2020 · April | 2020-04-01 | No tabular change |
| FY2021 | 2020-10-01 | No tabular change |
| FY2021 · 01-01 | 2021-01-01 | No tabular change |
| FY2022 | 2021-10-01 | No tabular change |
| FY2022 · 04-01 | 2022-04-01 | No tabular change |
| FY2023 | 2022-10-01 | No tabular change |
| FY2023 · 04-01 | 2023-04-01 | No tabular change |
| FY2024 | 2023-10-01 | No tabular change |
| FY2024 · 04-01 | 2024-04-01 | No tabular change |
| FY2025 | 2024-10-01 | No tabular change |
| FY2025 · 04-01 | 2025-04-01 | No tabular change |
| FY2026 | 2025-10-01 | No tabular change |
| FY2026 · April | 2026-04-01 | No tabular change |
| FY2027 | 2026-10-01 | No tabular change |
Explore the more specific codes in this category. Reference checks do not establish clinical appropriateness or guarantee reimbursement.